Cell signaling governs cellular behavior and is therefore subject to tight spatiotemporal 24 regulation. Signaling output is regulated by specialized cell membranes and vesicles which 25 contain unique combinations of lipids and proteins. The phospholipid phosphatidylinositol 4,5-26 bisphosphate, (PI(4,5)P2), an important component of the plasma membrane as well as other 27 subcellular membranes, is involved in multiple processes, including signaling. However, which 28 enzymes drive the formation and degradation of non-plasma membrane PI(4,5)P2, and their 29 impact on cell signaling and function at the organismal level are unknown. Here we show in a 30 mouse model that Paladin is a vascular PI(4,5)P2 phosphatase that regulates endosomal 31 signaling and angiogenesis. Paladin was localized to the endosomal and Golgi compartments, 32 and interacted with vascular endothelial growth factor receptor 2 (VEGFR2) in vitro and in 33 vivo. Loss of Paladin resulted in increased internalization of the receptor, over-activation of 34 extracellular regulated kinase, and hypersprouting of endothelial cells in the developing retina 35 of mice. These findings suggest that inhibition of Paladin, or other endosomal PI(4,5)P2 36 phosphatases, could be exploited to modulate VEGFR2 signaling and angiogenesis, when direct 37 and full inhibition of the receptor is not desirable. 38 42 Gordon et al. 2016). However, signaling is quantitatively and qualitatively distinct dependent 43 on the specialized membrane compartment (Di Paolo and De Camilli 2006). Key to the 44 maintenance of membrane specialization are lipid kinases and phosphatases that specifically 45 phosphorylate/dephosphorylate phospholipids with an inositol head group i.e. 46 phosphoinositides (PI). PIs are specifically distributed to generate 'membrane codes' on 47 intracellular vesicles and the plasma membrane (Di Paolo and De Camilli 2006, Lemmon 48 2008). These PIs together with Rab GTPases are required for the maintenance and coordination 49 of endocytosis and membrane trafficking (Jean and Kiger 2012) through recruitment of effector 50 proteins to assemble specific endocytic complexes (Botelho, Efe et al. 2008, Jin, Chow et al. 51 2008, Lemmon 2008, Chagpar, Links et al. 2010, Mizuno-Yamasaki, Medkova et al. 2010). 52 Consequently, as lipid kinases and phosphatases are key regulators of membrane identity and 53 function, they are also regulators of cell signaling. However, the kinases and phosphatases 54 involved in the generation of the specific PIs at distinct subcellular localizations are still not 55 fully identified and their roles at the organismal level are only partially known. 56 57 PIs are phosphorylated at the 3¢, 4¢, and 5¢ position of the inositol ring, giving rise to seven 58 different PI species. The main PIs in the plasma membrane, early endosomes, late endosomes, 59 and the Golgi apparatus are PI(4,5)P2, PI(3)P, PI(3,5)P2, and PI(4)P, respectively (Tan, Thapa 60 et al. 2015). These PI pools present in microdomains of membrane vesicles provide a unique 61 environment for signaling and sorting (Tan, Thapa et al. 2015).
INTRODUCTION
In the eukaryotic cell, membranes in different subcellular compartments play distinct roles in 40 cell signaling. Growth factor receptor signaling is initiated at the cell surface and continues after 41 internalization and during endosome trafficking (Lampugnani, Orsenigo et al. 2006 , Simons, Accordingly, we investigated the effect of PALD1 silencing on the phosphorylation of various 202 molecules involved in the VEGF-A/VEGFR2 signaling in HDMEC. In keeping with a more 203 efficient internalization of the receptor after VEGF-A stimulation of HDMEC, phosphorylation 204 of VEGFR2 normalized to total VEGFR2 was enhanced in PALD1 siRNA-treated cells after 205 VEGF-A stimulation compared with non-silenced cells (Figure 3a In this study, we explored the signaling role of Paladin. We show here for the first time that 289 Paladin binds to and dephosphorylates phosphoinositides. Paladin was localized to Rab4, -7, 290 and -11, and Golgi membranes, and was thus positioned to act as a regulator of endosomal 291 phosphoinositide content and, thereby, endosomal trafficking. Furthermore, loss of Pald1 292 expression led to enhanced VEGFR2 internalization after VEGF-A stimulation, rapid 293 trafficking of VEGFR2 through early endosomes, and increased pERK1/2 levels in vitro and in that Paladin is a Cys-based phosphatase, which forms its own subclass (IV). Whereas all the 305 neighboring phosphatase subclasses dephosphorylate phosphoinositides, they proposed, based 306 on structural similarity, that Paladin might possess inositol phosphatase activity (Alonso and 307 Pulido 2015). Indeed, we have demonstrated in this study that Paladin, while also binding 308 monophosphoinositides and PI(3,5)P2, preferentially dephosphorylates PI(4,5)P2 lipids, but not 309 other phosphoinositides or inositol phosphates. As has been shown for PTEN, the lipid-binding further studies are needed to formally verify this.
319
Paladin appears to be a PI(4,5)P2 phosphatase with a specific biological function, as has also 320 been observed for other PI(4,5)P2 phosphatases, which have similar substrate specificity but 321 play distinct biological roles. For example, syntaptojanins, endocytic PI(4,5)P2 phosphatases, Paladin appears to play a unique VEGF-A-regulated role by affecting VEGFR2 trafficking and 335 signaling. Indeed, we observed that following VEGF-A stimulation, VEGFR2 was more rapidly 336 internalized, with enhanced ERK1/2 phosphorylation, in PALD1 silenced cells than in the control cells. Disruption of VEGFR2 trafficking has also been shown to occur in Synectin 338 deficiency. Synectin null mice exhibit altered VEGFR2 signaling and insufficient arterial 339 formation as a consequence of prolonged trafficking through early endosomes which allows for 340 increased VEGFR2 dephosphorylation at pTyr1173 by tyrosine-protein phosphatase non-341 receptor type 1 (PTP1b) and reduced pERK1/2 (Lanahan, 2010). Hence, in the absence of 342 Pald1, the rapid internalization of VEGFR2 may allow its escape from dephosphorylation by 343 PTP1b and, thereby, increased pERK1/2 levels. Alternatively, VEGFR2 might recycle back to 344 the plasma membrane and initiate another round of phosphorylation in the absence of Paladin.
345
In line with this, we also observed increased pTyr1173 phosphorylation in HDMEC but did not suspended in assay buffer at 3000 pmol/well. The protein to be tested (30 µl of immunocomplexes) was 48 added and the reaction was stopped after 20-90 min depending on phosphoinositide to be tested by 49 adding an equal volume of molybdate dye solution (V2471 Promega) and after 15 min incubation at RT 50 absorbance at 600 nm was measured. Released phosphate was calculated by comparison to the amount 51 of free phosphate in positive control (3000 pmol of K2PO4). The colorimetric assay was performed in Phosphopeptide phosphatase activity was assessed by the radioactive assay using src-optimal peptide 54 and PKC-optimal peptide as previously described 2 . For immunoprecipitation, lysates were pre-cleared for 2 h at 4°C with unspecific goat IgG (Jackson 101
Immuno Research) and Protein-G sepharose 4 Fast Flow beads (GE Healthcare) and incubated overnight 102 at 4°C with goat anti-mouse VEGFR2 (R&D, AF644) or goat anti-human VEGFR2 (R&D, AF357). 103
The lysates were incubated with Protein-G sepharose beads for 1 h at 4°C and subsequently the beads 104 were washed five times with lysis buffer and denatured in 2x sample buffer (LifeTechnologies) at 95°C 105 for 5 min.
Lab software (BioRad). 123 124 Surface biotinylation assay 8.6, 150 mM NaCl, 1mM EDTA, 0.2% BSA (pH 8.6) for 3x 15 minutes. After washing cells were lysed 139 with RIPA buffer as described above. 140
Equal amounts of protein lysates were immunoprecipitated with streptavidin sepharose beads (GE 141
Healthcare) overnight at 4°C after which beads were washed extensively with RIPA buffer and 142 suspended in 2x NuPAGE LDS Sample Buffer (Invitrogen) with NuPAGE Sample Reducing Agent 143 (Invitrogen). Protein separation and western blotting was performed as described above. 144 150 retinas were permeabilized and blocked (0.1-0.5% Triton-X100, 0.05% sodium deoxycholate, 1% BSA, 151 2% FBS, 0.02% sodium azide in PBS, or 0.3% Triton-X100, 3% FBS, 3% donkey serum) for 1-2 h at 152 RT and stained overnight at 4°C using the following antibodies: rabbit anti-Erg (1:300, Abcam, 153 ab92513), rabbit anti-cyclinD1 (1:50, Thermo Scientific RM-9104), rabbit anti-pERK1/2 (1:100, Cell 154
Signaling #9101), rat anti-VEC (1:100, BD 555298) and rabbit anti-pY685 VEC (1:50, kind gift from 155 A litter of P7 pups and their mother and/or foster mother were exposed to 75% oxygen in a semi-sealed 169 oxygen chamber (ProOx 110 sensor and A-Chamber, Biospherix, Parish, NY) from P7 to P12, followed 170 by room oxygen from P12 to P15-P17. Pups were sacrificed at indicated time point and the eyes were 171 collected. To assess vascular permeability following OIR, P17 pups were warmed under a heat lamp 172 and then 50 µl of green fluorescent microspheres (1% solution of 25 nm FITC conjugated microsphere 173
Fluoro-MAX G25, Thermo scientific, Fremont, CA) were injected via tail vein using a 30-gauge insulin 174 syringe while the mice were under temporary isoflurane anaesthesia. Following injection, microspheres 175 were allowed to circulate for 15 minutes before the mice were once more placed under isoflurane 176 anaesthesia. PBS was flushed through the vasculature via cardiac perfusion to remove excess 177 microspheres, which had not extravasated followed by 4% PFA for tissue fixation. Eyes were enucleated 178 and fixed in 4% PFA at RT for 30 minutes before the retinas were dissected and immunostained with 179 isolectinB4 conjugated to Alexa647 and pERK1/2 as described. 180
To visualize Pald1 expression after OIR, eyes from P17 pups were collected and processed for lacZ 181 staining as described below. 
